Thomas Goetz

Journalist, entrepreneur, haver of notions.

[Thomas Goetz @tgoetz]

@chrissyfarr @Farzad_MD and when this happens it's not even "medicine" - it's public health! :)

[Thomas Goetz @tgoetz]

@DShaywitz @nytimes @DanielJDrucker @jflier you are right. the weight loss showed up in normal doses of Byetta. and the NYT wrote about it at the time! https://t.co/V7bVCYP0jN

[Thomas Goetz @tgoetz]

San Francisco, take notice

[Scott Lincicome @scottlincicome]

"Austin’s Surge of New Housing Construction Drove Down Rents" (even as its population grew)
https://t.co/Mi7GYtLlbz

[Thomas Goetz @tgoetz]

@cwhogg @derekflanz @maxmarchione vaccines might serve as examples too - but maybe not.

[Thomas Goetz @tgoetz]

@matthewherper +1

[Thomas Goetz @tgoetz]

@adamcifu Thanks for listening Adam!

[Thomas Goetz @tgoetz]

This is my version of "Blue Steel" I guess.

thank you to @annewoj23 and @23andMe for having me visit!

[23andMe @23andMe]

Leading with science means starting with a story, said journalist @tgoetz during a fireside chat with @annewoj23. He spoke about his podcast Drug Story, how to make science accessible for audiences, and how 23andMe's work continues to help people better understand genomics.

[Thomas Goetz @tgoetz]

Whatever happened to pharmacogenomics - matching drugs to our DNA? In new episode of Drug Story, @EricTopol tells me what happened - and why it still holds promise.
https://t.co/oOTQRVTPmu

[Thomas Goetz @tgoetz]

strange request: Has anyone taken ivermectin for parasites? Like, worms?

DM me!

[Thomas Goetz @tgoetz]

How did the idea of pain as a "5th vital sign" lead to the opioid epidemic? And why is it so hard to find something new? New episode of Drug Story on chronic pain!

https://t.co/InUULFtMz6

[Joseph Sirven, MD @jsirven]

ICYMI: On our 2/7 show @WJCTNews & @FCConair we explore Drug Stories: Promise & Peril — with journalist @tgoetz on his new podcast Drug Story + Dr. K. Hatfield of @ViiVHC on #PrEP.
Join us @carlyakramer @heatherschatz @asuhealth

https://t.co/EHW345MnsK

[Thomas Goetz @tgoetz]

@PescaGist @pescami so appreciative of the conversation, Mike. thank you for having me on and challenging my priors :)

[The Gist @PescaGist]

@tgoetz @pescami https://t.co/de3HvW1hAW

[Thomas Goetz @tgoetz]

i need to improve my lighting.

[The Gist @PescaGist]

“Lock-in” isn’t just an Apple thing.
Thomas Goetz (@tgoetz), creator of the Drug Story podcast, explains how EpiPen built a moat: train school nurses and teachers on one device, and the “similar but different” competitor becomes harder to adopt.

@pescami
#healthcare #pharma #economics

[Thomas Goetz @tgoetz]

Mike Pesca kept me on my toes! He is super informed about medicine, and this was a great conversation (part 1!)

[The Gist @PescaGist]

Today on the Gist: Thomas Goetz (@tgoetz) joins the show to discuss his new podcast Drug Story, starting with the chain from FDR’s death to cholesterol science, statins, and the cold math behind drug effectiveness. The conversation moves through Lipitor and EpiPens to show how evolving medical knowledge, good intentions, and pharmaceutical incentives can quietly reshape public health at massive scale. Plus, Trump is perhaps rethinking his Minnesota deployments, as the fire trucks exit. In the spiel a look at why the word “pretext” keeps surfacing in descriptions of Trump administration ICE actions, especially in Minnesota. What the term actually means, why it is often misapplied, and what its ubiquity reveals about how this administration justifies force before retreating.

@pescami
#drugstory #ice #Minneapolis #lipitor #epipens #PublicHealth

[The Gist @PescaGist]

Today on the Gist: Thomas Goetz (@tgoetz) joins the show to discuss his new podcast Drug Story, starting with the chain from FDR’s death to cholesterol science, statins, and the cold math behind drug effectiveness. The conversation moves through Lipitor and EpiPens to show how evolving medical knowledge, good intentions, and pharmaceutical incentives can quietly reshape public health at massive scale. Plus, Trump is perhaps rethinking his Minnesota deployments, as the fire trucks exit. In the spiel a look at why the word “pretext” keeps surfacing in descriptions of Trump administration ICE actions, especially in Minnesota. What the term actually means, why it is often misapplied, and what its ubiquity reveals about how this administration justifies force before retreating.

@pescami
#drugstory #ice #Minneapolis #lipitor #epipens #PublicHealth

[Thomas Goetz @tgoetz]

My new podcast, Drug Story, is climbing the charts on Apple Podcasts - now 53 on Top Shows (Society & Culture).

New episode just dropped on Ozempic & Obesity. I promise it's a story you haven't heard about the obesity epidemic.

Listen now! https://t.co/P5QG4ngZuP

[David Eagleman @davideagleman]

With obesity rates at 40%, are we forced to confront the interactions between biology, behavior, & environment... and rethink the word “choice” with more nuance? Join this week w guest Thomas Goetz (@tgoetz) for questions at the intersection of medicine, economics, & culture.

[David Eagleman @davideagleman]

Why was there such an upsurge in peanut allergies? Learn about the fascinating world of prescription drugs -- some of the most important & complex elements in our world -- with science journalist Thomas Goetz (@tgoetz).
https://t.co/9IFACktMLd

[David Eagleman @davideagleman]

Is it 'cheating' to use a weight loss drug? Catch this week's Inner Cosmos to learn how meds interact with society with science journalist Thomas Goetz (@tgoetz).
https://t.co/9IFACktMLd